|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"yang james chih hsin"
Showing items 1-50 of 101 (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2022-08-03T05:16:42Z |
Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front-line chemotherapy regimens
|
Ma, Wei-Li; Lin, Chia-Chi; Feng-Ming Hsu; Lee, Jang-Ming; Chen, Jin-Shing; YEN-LIN HUANG; Chang, Yih-Leong; Chang, Chin-Hao; Yang, James Chih-Hsin |
| 臺大學術典藏 |
2022-03-29 |
Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front-line chemotherapy regimens
|
Yang, James Chih-Hsin; Chang, Chin-Hao; Chang, Yih-Leong; Huang, Yen-Lin; Chen, Jin-Shing; Lee, Jang-Ming; Feng-Ming Hsu; Lin, Chia-Chi; MA, WEI-LI |
| 臺大學術典藏 |
2021-11-29T06:00:54Z |
Precision Management of Advanced Non-Small Cell Lung Cancer
|
CHING-YAO YANG; Yang, James Chih-Hsin; Yang, Pan-Chyr |
| 臺大學術典藏 |
2021-11-29T05:59:19Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
CHING-YAO YANG; Liao, Wei-Yu; Ho, Chao-Chi; Chen, Kuan-Yu; Tsai, Tzu-Hsiu; Hsu, Chia-Lin; Liu, Yi-Nan; Su, Kang-Yi; Chang, Yih-Leong; Wu, Chen-Tu; Liao, Bin-Chi; Hsu, Chia-Chi; Hsu, Wei-Hsun; LEE JIH-HSIANG; Lin, Chia-Chi; Shih, Jin-Yuan; Yang, James Chih-Hsin; Yu, Chong-Jen |
| 臺大學術典藏 |
2021-11-29T05:57:16Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M-Positive NSCLC
|
Liao, Bin-Chi; Hsu, Wei-Hsun; LEE JIH-HSIANG; CHING-YAO YANG; Tsai, Tzu-Hsiu; Liao, Wei-Yu; Ho, Chao-Chi; Lin, Chia-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Soo, Ross A; Yang, James Chih-Hsin |
| 臺大學術典藏 |
2021-11-29T05:27:58Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M-Positive NSCLC
|
Liao, Bin-Chi; Hsu, Wei-Hsun; LEE JIH-HSIANG; Yang, Ching-Yao; TZU-HSIU TSAI; Liao, Wei-Yu; Ho, Chao-Chi; Lin, Chia-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Soo, Ross A; Yang, James Chih-Hsin |
| 臺大學術典藏 |
2021-11-29T03:22:49Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M-Positive NSCLC
|
Liao, Bin-Chi; Hsu, Wei-Hsun; LEE JIH-HSIANG; Yang, Ching-Yao; Tsai, Tzu-Hsiu; WEI-YU LIAO; Ho, Chao-Chi; Lin, Chia-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Soo, Ross A; Yang, James Chih-Hsin |
| 臺大學術典藏 |
2021-11-17T06:28:35Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M-Positive NSCLC
|
Liao, Bin-Chi; Hsu, Wei-Hsun; LEE JIH-HSIANG; Yang, Ching-Yao; Tsai, Tzu-Hsiu; Liao, Wei-Yu; CHAO-CHI HO; Lin, Chia-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Soo, Ross A; Yang, James Chih-Hsin |
| 臺大學術典藏 |
2021-11-02T06:58:32Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M-Positive NSCLC
|
Liao, Bin-Chi; Hsu, Wei-Hsun; LEE JIH-HSIANG; Yang, Ching-Yao; Tsai, Tzu-Hsiu; Liao, Wei-Yu; CHAO-CHI HO; Lin, Chia-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Soo, Ross A; Yang, James Chih-Hsin |
| 臺大學術典藏 |
2021-05-05T05:28:58Z |
The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation
|
Shang-Gin Wu;Yu, Chong-Jen;Yang, James Chih-Hsin;Shih, Jin-Yuan; SHANG-GIN WU; Yu, Chong-Jen; Yang, James Chih-Hsin; Shih, Jin-Yuan |
| 臺大學術典藏 |
2021-03-22T07:41:45Z |
Circulating Exosomal Integrin β3 Is Associated with Intracranial Failure and Survival in Lung Cancer Patients Receiving Cranial Irradiation for Brain Metastases: A Prospective Observational Study
|
Chen, Guann-Yiing; Cheng, Jason Chia-Hsien; YA-FANG CHEN; Yang, James Chih-Hsin; Hsu, Feng-Ming |
| 臺大學術典藏 |
2020-04-09T09:30:38Z |
Cytotoxic Chemotherapy as First-Line Therapy for Advanced Non-Small-Cell Lung Cancer in Taiwan: Daily Practice
|
Liang, Yi-Hsin; Shao, Yu-Yun; Liao, Bin-Chi; Lee, Ho-Sheng; Yang, James Chih-Hsin; Chen, Ho-Min; Chiang, Chun-Ju; Cheng, Ann-Lii; Lai, Mei-Shu |
| 臺大學術典藏 |
2019-12-18T06:15:22Z |
Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations
|
Yang, James Chih-Hsin; Shih, Jin-Yuan;SHENG KAI LIANG;JEN-CHUNG KO; JEN-CHUNG KO; SHENG KAI LIANG; Yang, James Chih-Hsin; Shih, Jin-Yuan |
| 臺大學術典藏 |
2019-03-04T08:13:58Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin, Shu Yung;Yang, Ching Yao;Bin-Chi Liao;Chao-Chi Ho;Wei-Yu Liao;Chen, Kuan-Yu;Tsai, Tzu Hsiu;Chia-Lin Hsu;Hsu, Wei Hsun;Kang-Yi Su;Yih-Leong Chang;Lee, Jih Hsiang;Lin, Chia Chi;Jin-Yuan Shih;Yang, James Chih Hsin;Chong-Jen Yu; Lin, Shu Yung; Yang, Ching Yao; BIN-CHI LIAO; CHAO-CHI HO; WEI-YU LIAO; Chen, Kuan-Yu; Tsai, Tzu Hsiu; CHIA-LIN HSU; Hsu, Wei Hsun; KANG-YI SU; YIH-LEONG CHANG; Lee, Jih Hsiang; Lin, Chia Chi; JIN-YUAN SHIH; Yang, James Chih Hsin; Chong-Jen Yu |
| 臺大學術典藏 |
2019-03-04T07:51:37Z |
Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion
|
Yang, James Chih Hsin;Liu, Yi-Nan;Wu, Shang-Gin;JIN-YUAN SHIH;CHONG-JEN YU; Wu, Shang-Gin; Liu, Yi-Nan; Chong-Jen Yu; Yang, James Chih Hsin; JIN-YUAN SHIH |
| 臺大學術典藏 |
2019-03-04T06:50:19Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Yang, James Chih Hsin;Lin, Zhong Zhe;Lee, Jih Hsiang;Yang, Ching Yao;Lin, Yen Ting;Chen, Kuan-Yu;CHONG-JEN YU;JIN-YUAN SHIH;CHIA-LIN HSU;CHAO-CHI HO;WEI-YU LIAO;JIN-SHING CHEN; Lin, Yen Ting; JIN-SHING CHEN; WEI-YU LIAO; CHAO-CHI HO; CHIA-LIN HSU; Yang, Ching Yao; Chen, Kuan-Yu; Lee, Jih Hsiang; Lin, Zhong Zhe; JIN-YUAN SHIH; Yang, James Chih Hsin; Chong-Jen Yu |
| 臺大學術典藏 |
2018-09-10T15:38:24Z |
Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis
|
楊志新;蘇剛毅;廖唯昱;余忠仁;何肇基;阮聖元;施金元; 楊志新;蘇剛毅;廖唯昱;余忠仁;何肇基;阮聖元;施金元; Chen, Li-Yang; Chen, Li-Yang; Chong-Jen Yu; Molina-Vila, Miguel A.; WEI-YU LIAO; KAI-LUN YU; Ruan, Sheng-Yuan; Ruan, Sheng-Yuan; Ruan, Sheng-Yuan; Su, Kang-Yi; Su, Kang-Yi; CHAO-CHI HO; KANG-YI SU; Liao, Wei-Yu; Liao, Wei-Yu; Yu, Kai-Lun; Yu, Kai-Lun; JIN-YUAN SHIH; Yu, Kai-Lun; Ho, Chao-Chi; Ho, Chao-Chi; Shih, Jin-Yuan; Shih, Jin-Yuan; Shih, Jin-Yuan; Yu, Chong-Jen; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, James Chih-Hsin; Rosell, Rafael; Rosell, Rafael; Yang, Pan-Chyr; Yang, Pan-Chyr; Yang, Pan-Chyr; Chen, Li-Yang;Molina-Vila, Miguel A.;Ruan, Sheng-Yuan;Su, Kang-Yi;Liao, Wei-Yu;Yu, Kai-Lun;Ho, Chao-Chi;Shih, Jin-Yuan;Yu, Chong-Jen;Yang, James Chih-Hsin;Rosell, Rafael;Yang, Pan-Chyr; Chen, L.-Y. and Molina-Vila, M.A. and Ruan, S.-Y. and Su, K.-Y. and Liao, W.-Y. and Yu, K.-L. and Ho, C.-C. and Shih, J.-Y. and Yu, C.-J. and Yang, J.C.H. and Rosell, R. and Yang, P.-C. |
| 臺大學術典藏 |
2018-09-10T15:34:42Z |
Anaplastic Lymphoma Kinase (ALK) Kinase Domain Mutation Following ALK Inhibitor(s) Failure in Advanced ALK Positive Non–Small-Cell Lung Cancer: Analysis and Literature Review
|
Shih, Jin-Yuan; Shih, Jin-Yuan; Yang, James Chih-Hsin; Lin, Yen-Ting;Yu, Chong-Jen;Yang, James Chih-Hsin;Shih, Jin-Yuan; Lin, Y.-T. and Yu, C.-J. and Yang, J.C.-H. and Shih, J.-Y.; 楊志新;余忠仁;林奕廷;林怡岑;施金元; 楊志新;余忠仁;林奕廷;林怡岑;施金元; Lin, Yen-Ting; Chong-Jen Yu; JIN-YUAN SHIH; Yu, Chong-Jen; Yu, Chong-Jen; Yang, James Chih-Hsin |
| 臺大學術典藏 |
2018-09-10T15:34:42Z |
Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations
|
Chen, Y.-F. and Hsieh, M.-S. and Wu, S.-G. and Chang, Y.-L. and Yu, C.-J. and Yang, J.C.-H. and Yang, P.-C. and Shih, J.-Y.; Chen, Yen-Fu;Hsieh, Min-Shu;Wu, Shang-Gin;Chang, Yih-Leong;Yu, Chong-Jen;Yang, James Chih-Hsin;Yang, Pan-Chyr;Shih, Jin-Yuan; 楊志新;張逸良;楊泮池;余忠仁;謝明書;吳尚俊;陳瑛芳;施金元; 楊志新;張逸良;楊泮池;余忠仁;謝明書;吳尚俊;陳瑛芳;施金元; Chen, Yen-Fu; MIN-SHU HSIEH; Hsieh, Min-Shu; YIH-LEONG CHANG; Wu, Shang-Gin; Chong-Jen Yu; Chang, Yih-Leong; JIN-YUAN SHIH; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, Pan-Chyr; Shih, Jin-Yuan |
| 臺大學術典藏 |
2018-09-10T15:32:30Z |
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients
|
Wu, Shang-Gin;Liu, Yi-Nan;Tsai, Meng-Feng;Chang, Yih-Leong;Yu, Chong-Jen;Yang, Pan-Chyr;Yang, James Chih-Hsin;Wen, Yueh-Feng;Shih, Jin-Yuan; Wu, S-G. and Liu, Y.-N. and Tsai, M.-F. and Chang, Y.-L. and Yu, C.-J. and Yang, P.-C. and Yang, J.C.-H. and Wen, Y.-F. and Shih, J.-Y.; 楊志新;張逸良;楊泮池;余忠仁;溫岳峰;吳尚俊;施金元; YIH-LEONG CHANG; Tung, Li-Chen; Wu, Shang-Gin; Liu, Yi-Nan; Lin, Chin-Kai; Chong-Jen Yu; Hsieh, Ching-Lin; Tsai, Meng-Feng; JIN-YUAN SHIH; Chang, Yih-Leong; Chen, Ching-Chi; Huang, Chin-Tsan; Yu, Chong-Jen; Wang, Chun-Hou; Yang, Pan-Chyr; Yang, James Chih-Hsin; Wen, Yueh-Feng; Shih, Jin-Yuan; ??M??; 楊志新; 張逸良; 楊泮池; 余忠仁; 溫岳峰; 吳尚俊; 施金元 |
| 臺大學術典藏 |
2018-09-10T15:27:17Z |
Protein-bound uremic toxins induce tissue remodeling by targeting the EGF receptor
|
Sun, Chiao-Yin;Young, Guang-Huar;Hsieh, Yu-Ting;Chen, Yau-Hung;Wu, Mai-Szu;Wu, Vin-Cent;Lee, Jia-Hung;Lee, Chin-Chan; Sun, C.-Y. and Young, G.-H. and Hsieh, Y.-T. and Chen, Y.-H. and Wu, M.-S. and Wu, V.-C. and Lee, J.-H. and Lee, C.-C.; 吳允升; Sun, Chiao-Yin; VIN-CENT WU; Wu, Shang-Gin; Liu, Yi-Nan; Young, Guang-Huar; Tsai, Meng-Feng; Hsieh, Yu-Ting; Chang, Yih-Leong; Chen, Yau-Hung; Yu, Chong-Jen; Wu, Mai-Szu; Yang, Pan-Chyr; Wu, Vin-Cent; Lee, Jia-Hung; Yang, James Chih-Hsin; Wen, Yueh-Feng; Lee, Chin-Chan; Shih, Jin-Yuan; 楊志新; 張逸良; 楊泮池; 余忠仁; 溫岳峰; 吳尚俊; 施金元 |
| 臺大學術典藏 |
2018-09-10T15:24:38Z |
The response, outcome and toxicity of aggressive palliative thoracic radiotherapy for metastatic non-small cell lung cancer patients with controlled extrathoracic diseases
|
Hsu, Feng-Ming; Yousfi, Rahima; Chen, Yu-Hsuan; Chen, Yu-Hsuan; Shih, Jin-Yuan; Shih, Jin-Yuan; Mohan, Viswaraman; Posch, Wilfried; Lin, Zhong-Zhe; Lin, Zhong-Zhe; Wilflingseder, Doris; Lan, Keng-Hsueh; Lan, Keng-Hsueh; Moog, Christiane; Cheng, Ann-Lii; Kuo, Sung-Hsin; Kodama, Eiichi N.; Kuo, Sung-Hsin; Clayette, Pascal; Lortat-Jacob, Hugues; Wu, Yuntao; 張淑媛; Chiang, Y. and Yang, J.C.-H. and Hsu, F.-M. and Chen, Y.-H. and Shih, J.-Y. and Lin, Z.-Z. and Lan, K.-H. and Cheng, A.-L. and Kuo, S.-H.; Chiang, Yun;Yang, James Chih-Hsin;Hsu, Feng-Ming;Chen, Yu-Hsuan;Shih, Jin-Yuan;Lin, Zhong-Zhe;Lan, Keng-Hsueh;Cheng, Ann-Lii;Kuo, Sung-Hsin; 楊志新;郭頌鑫;鄭安理;陳育瑄;藍耿學;施金元;許峰銘; 楊志新;郭頌鑫;鄭安理;陳育瑄;藍耿學;施金元;許峰銘; JIN-YUAN SHIH; Connell, Bridgette Janine; Chiang, Yun; Yang, James Chih-Hsin; Chang, Sui-Yuan; Yang, James Chih-Hsin; ANN-LII CHENG; Prakash, Ekambaranellore |
| 臺大學術典藏 |
2018-09-10T15:18:47Z |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis
|
林家齊;楊志新;廖斌志;陳雅芳;余忠仁;何肇基;施金元;李日翔;張晉豪; Liao, Bin-Chi;Lee, Jih-Hsiang;Lin, Chia-Chi;Chen, Ya-Fang;Chang, Chin-Hao;Ho, Chao-Chi;Shih, Jin-Yuan;Yu, Chong-Jen;Yang, James Chih-Hsin; Chong-Jen Yu; Liao, Bin-Chi; Liao, Bin-Chi; YA-FANG CHEN; Lee, Jih-Hsiang; Lee, Jih-Hsiang; CHAO-CHI HO; Lin, Chia-Chi; Lin, Chia-Chi; Chen, Ya-Fang; JIN-YUAN SHIH; Chen, Ya-Fang; Chang, Chin-Hao; Ho, Chao-Chi; Ho, Chao-Chi; Shih, Jin-Yuan; Shih, Jin-Yuan; Yu, Chong-Jen; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, James Chih-Hsin |
| 臺大學術典藏 |
2018-09-10T15:17:53Z |
Treating patients with ALK -positive non-small cell lung cancer: Latest evidence and management strategy
|
Liao, B.-C. and Lin, C.-C. and Shih, J.-Y. and Yang, J.C.-H.; Liao, Bin-Chi;Lin, Chia-Chi;Shih, Jin-Yuan;Yang, James Chih-Hsin; 林家齊;楊志新;廖斌志;施金元; 林家齊;楊志新;廖斌志;施金元; Liao, Bin-Chi; Lin, Chia-Chi; Shih, Jin-Yuan; Yang, James Chih-Hsin |
| 臺大學術典藏 |
2018-09-10T15:17:53Z |
Rapid Response to Sunitinib in a Patient with Lung Adenocarcinoma Harboring KIF5B-RET Fusion Gene
|
Wu, H. and Shih, J.-Y. and Yang, J.C.-H.; Wu, Hsu;Shih, Jin-Yuan;Yang, James Chih-Hsin; Wu, Hsu;Shih, Jin-Yuan;Yang, James Chih-Hsin; 楊志新;施金元; Wu, Hsu; JIN-YUAN SHIH; Shih, Jin-Yuan; Shih, Jin-Yuan; Yang, James Chih-Hsin; Yang, James Chih-Hsin |
| 臺大學術典藏 |
2018-09-10T15:17:32Z |
Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion
|
Tsai, Tzu-Hsiu;Wu, Shang-Gin;Hsieh, Min-Shu;Yu, Chong-Jen;Yang, James Chih-Hsin;Shih, Jin-Yuan; Tsai, Tzu-Hsiu;Wu, Shang-Gin;Hsieh, Min-Shu;Yu, Chong-Jen;Yang, James Chih-Hsin;Shih, Jin-Yuan; Tsai, T.-H. and Wu, S.-G. and Hsieh, M.-S. and Yu, C.-J. and Yang, J.C.H. and Shih, J.-Y.; 楊志新;余忠仁;謝明書;吳尚俊;蔡子修;施金元; MIN-SHU HSIEH; Tsai, Tzu-Hsiu; CHONG-JEN YU; Wu, Shang-Gin; Hsieh, Min-Shu; JIN-YUAN SHIH; Hsieh, Min-Shu; Yu, Chong-Jen; CHIH-HSIN YANG; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, James Chih-Hsin; Shih, Jin-Yuan; Shih, Jin-Yuan |
| 臺大學術典藏 |
2018-09-10T14:49:59Z |
Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations
|
Chen, Yen-Fu;Hsieh, Min-Shu;Wu, Shang-Gin;Chang, Yih-Leong;Shih, Jin-Yuan;Liu, Yi-Nan;Tsai, Meng-Feng;Tsai, Tzu-Hsiu;Yu, Chong-Jen;Yang, James Chih-Hsin;Yang, Pan-Chyr; Chen, Y.-F. and Hsieh, M.-S. and Wu, S.-G. and Chang, Y.-L. and Shih, J.-Y. and Liu, Y.-N. and Tsai, M.-F. and Tsai, T.-H. and Yu, C.-J. and Yang, J.C.-H. and Yang, P.-C.; 楊志新;張逸良;楊泮池;余忠仁;謝明書;吳尚俊;陳瑛芳;蔡子修;施金元; 楊志新;張逸良;楊泮池;余忠仁;謝明書;吳尚俊;陳瑛芳;蔡子修;施金元; MIN-SHU HSIEH; Chen, Yen-Fu; Hsieh, Min-Shu; YIH-LEONG CHANG; Wu, Shang-Gin; CHONG-JEN YU; JIN-YUAN SHIH; Chang, Yih-Leong; CHIH-HSIN YANG; Shih, Jin-Yuan; Liu, Yi-Nan; Tsai, Meng-Feng; Tsai, Tzu-Hsiu; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, Pan-Chyr |
| 臺大學術典藏 |
2018-09-10T09:13:19Z |
Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR
|
Chung, Kuei-Pin;Wu, Shang-Gin;Wu, Jenn-Yu;Yang, James Chih-Hsin;Yu, Chong-Jen;Wei, Pin-Fei;Shih, Jin-Yuan;Yang, Pan-Chyr; Chung, K.-P. and Wu, S.-G. and Wu, J.-Y. and Yang, J.-H. and Yu, C.-J. and Wei, P.-F. and Shih, J.-Y. and Yang, P.-C.; 楊泮池 ;余忠仁 ;衛品妃 ;吳尚俊 ;施金元 ;巫震宇; Chong-Jen Yu; Chung, Kuei-Pin; Wu, Shang-Gin; PAN-CHYR YANG; KUEI-PIN CHUNG; Wu, Jenn-Yu; Yang, James Chih-Hsin; JIN-YUAN SHIH; Yu, Chong-Jen; Wei, Pin-Fei; Shih, Jin-Yuan; Yang, Pan-Chyr |
| 臺大學術典藏 |
2018-09-10T08:38:57Z |
Subconjunctival injection of bevacizumab in the treatment of corneal neovascularization associated with lipid deposition
|
Chu, H.-S. and Hu, F.-R. and Yang, C.-M. and Yeh, P.-T. and Chen, Y.-M. and Hou, Y.-C. and Chen, W.-L.; 朱筱桑;胡芳蓉;楊中美;葉伯廷;陳彥名;侯育致; CHU, HSIAO-SANG;HU, FUNG-RONG;YANG, CHUNG-MAY;YEH, PO-TING;CHEN, YAN-MING;HOU, YU-CHIH;CHEN, WEI-LI; YU-CHIH HOU; Lin, Yen-Ting; Wang, Yu-Fen; CHUNG-MAY YANG; WEI-LI CHEN; Yang, James Chih-Hsin; Yu, Chong-Jen; YAN-MING CHEN; Wu, Shang-Gin; PO-TING YEH; FUNG-RONG HU; Shih, Jin-Yuan; Yang, Pan-Chyr; CHU, HSIAO-SANG; HU, FUNG-RONG; YANG, CHUNG-MAY; YEH, PO-TING; CHEN, YAN-MING; HOU, YU-CHIH; CHEN, WEI-LI; ���ӷs; �����; �E����; �L����; �d�|�T; �I����; ������ |
| 臺大學術典藏 |
2018-09-10T06:48:43Z |
Recurrent advancing wavelike epitheliopathy from the opposite side of the initial presentation
|
FUNG-RONG HU; Chu, HS; Wu, Shang-Gin; I-JONG WANG; Hu, FR; Chang, Yih-Leong; Wang, IJ; Shih, Jin-Yuan; Hou, YC; Chen, WL.; Liu, Yi-Nan; Tsai, Meng-Feng; Tsai, Tzu-Hsiu; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, Pan-Chyr; 楊志新; 張逸良; 楊泮池; 余忠仁; 謝明書; 吳尚俊; 陳瑛芳; 蔡子修; 施金元; Hsieh, Min-Shu; Chen, Yen-Fu; WEI-LI CHEN; Huang, YH; HUANG, YU-HSUN;CHU, HSIAO-SANG;HU, FUNG -RONG;WANG, I-JONG;HOU, YU-CHI;CHEN, WEI-LI; 黃昱勳;朱筱桑;胡芳蓉;王一中;侯鈺琪;陳偉勵; Huang, Y.-H. and Chu, H.-S. and Hu, F.-R. and Wang, I.-J. and Hou, Y.-C. and Chen, W.-L.; Huang, YH;Chu, HS;Hu, FR;Wang, IJ;Hou, YC;Chen, WL. |
| 國立臺灣大學 |
2016 |
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients
|
Wu, Shang-Gin; Liu, Yi-Nan; Tsai, Meng-Feng; Chang, Yih-Leong; Yu, Chong-Jen; Yang, Pan-Chyr; Yang, James Chih-Hsin; Wen, Yueh-Feng; Shih, Jin-Yuan; 楊志新; 張逸良; 楊泮池; 余忠仁; 溫岳峰; 吳尚俊; 施金元 |
| 國立臺灣大學 |
2016 |
Efficacy of of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion-Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populations
|
Chen, Yen-Fu; Hsieh, Min-Shu; Wu, Shang-Gin; Chang, Yih-Leong; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, Pan-Chyr; Shih, Jin-Yuan; 楊志新; 張逸良; 楊泮池; 余忠仁; 謝明書; 吳尚俊; 陳瑛芳; 施金元 |
| 國立臺灣大學 |
2016 |
Update on recent preclinical and clinical studies of T790M mutant-specific irreversible epidermal growth factor receptor tyrosine kinase inhibitors
|
Liao, Bin-Chi; Lin, Chia-Chi; Lee, Jih-Hsiang; Yang, James Chih-Hsin; 林家齊; 楊志新; 廖斌志; 李日翔 |
| 國立臺灣大學 |
2016 |
Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis
|
Chen, Li-Yang; Molina-Vila, Miguel A.; Ruan, Sheng-Yuan; Su, Kang-Yi; Liao, Wei-Yu; Yu, Kai-Lun; Ho, Chao-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Yang, James Chih-Hsin; Rosell, Rafael; Yang, Pan-Chyr; 楊志新; 蘇剛毅; 廖唯昱; 余忠仁; 何肇基; 阮聖元; 施金元 |
| 國立臺灣大學 |
2016 |
Safety of gefitinib in non-small cell lung cancer treatment
|
Hsiue, Emily Han-Chung; Lee, Jih-Hsiang; Lin, Chia-Chi; Yang, James Chih-Hsin; 林家齊; 楊志新; 李日翔 |
| 國立臺灣大學 |
2016 |
Cytotoxic Chemotherapy as First-Line Therapy for Advanced Non-Small-Cell Lung Cancer in Taiwan: Daily Practice
|
Liang, Yi-Hsin; Shao, Yu-Yun; Liao, Bin-Chi; Lee, Ho-Sheng; Yang, James Chih-Hsin; Chen, Ho-Min; Chiang, Chun-Ju; Cheng, Ann-Lii; Lai, Mei-Shu; 梁逸歆; 楊志新; 邵幼雲; 廖斌志; 賴美淑; 鄭安理 |
| 國立臺灣大學 |
2016 |
Anaplastic Lymphoma Kinase (ALK) Kinase Domain Mutation Following ALK Inhibitor(s) Failure in Advanced ALK Positive Non-Small-Cell Lung Cancer: Analysis and Literature Review
|
Lin, Yen-Ting; Yu, Chong-Jen; Yang, James Chih-Hsin; Shih, Jin-Yuan; 楊志新; 余忠仁; 林奕廷; 林怡岑; 施金元 |
| 國立臺灣大學 |
2016 |
Profile of the therascreen (R) EGFR RGQ PCR kit as a companion diagnostic for gefitinib in non-small cell lung cancer
|
Hsiue, Emily Han-Chung; Lee, Jih-Hsiang; Lin, Chia-Chi; Yang, James Chih-Hsin; 林家齊; 楊志新; 李日翔 |
| 大葉大學 |
2015-04 |
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer.
|
Liu, Yi-Nan;Chang, Tzu-Hua;Tsai, Meng-Feng;Wu, Shang-Gin;Tsai, Tzu-Hsiu;Chen, Hsuan-Yu;Yu, Sung-Liang;Yang, James Chih-Hsin;Shih, Jin-Yuan |
| 國立臺灣大學 |
2015 |
Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion
|
Tsai, Tzu-Hsiu; Wu, Shang-Gin; Hsieh, Min-Shu; Yu, Chong-Jen; Yang, James Chih-Hsin; Shih, Jin-Yuan; 楊志新; 余忠仁; 謝明書; 吳尚俊; 蔡子修; 施金元 |
| 國立臺灣大學 |
2015 |
Comparative Effectiveness of First-Line Platinum-Based Chemotherapy Regimens for Advanced Lung Squamous Cell Carcinoma
|
Liao, Bin-Chi; Shao, Yu-Yun; Chen, Ho-Min; Shau, Wen-Yi; Lin, Zhong-Zhe; Kuo, Raymond Nienchen; Lai, Chiu-Ling; Chen, Kuo-Hsing; Cheng, Ann-Lii; Yang, James Chih-Hsin; Lai, Mei-Shu; 楊志新; 邵幼雲; 廖斌志; 賴美淑; 林宗哲; 鄭安理; 郭年真; 陳國興 |
| 國立臺灣大學 |
2015 |
Advanced non-small cell lung cancer in the elderly: The impact of age and comorbidities on treatment modalities and patient prognosis
|
Hsu, Chia-Lin; Chen, Jen-Hau; Chen, Kuan-Yu; Shih, Jin-Yuan; Yang, James Chih-Hsin; Yu, Chong-Jen; Yang, Pan-Chyr; 楊志新; 楊泮池; 許嘉林; 陳冠宇; 余忠仁; 陳人豪; 施金元 |
| 國立臺灣大學 |
2015 |
First-in-human phase I study of EGF816, a third generation, mutant-selective EGFR tyrosine kinase inhibitor, in advanced non-small cell lung cancer (NSCLC) harboring T790M.
|
Tan, Daniel Shao-Weng; Seto, Takashi; Leighl, Natasha B.; Riely, Gregory J.; Sequist, Lecia V.; Felip, Enriqueta; Wolf, Juergen; Yang, James Chih-Hsin; Matushansky, Igor; Yu, Xiaolu; Schmitz, Shu-Fang Hsu; Cui, Xiaoming; Kim, Dong-Wan; 楊志新 |
| 國立臺灣大學 |
2015 |
How to use afatinib in clinical practice
|
Yang, James Chih-Hsin; 楊志新 |
| 國立臺灣大學 |
2015 |
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer
|
Liu, Yi-Nan; Chang, Tzu-Hua; Tsai, Meng-Feng; Wu, Shang-Gin; Tsai, Tzu-Hsiu; Chen, Hsuan-Yu; Yu, Sung-Liang; Yang, James Chih-Hsin; Shih, Jin-Yuan; 楊志新; 俞松良; 吳尚俊; 蔡子修; 施金元 |
| 國立臺灣大學 |
2015 |
Influence of dose adjustment on afatinib safety and efficacy in patients (pts) with advanced EGFR mutation-positive (EGFRm plus ) non-small cell lung cancer (NSCLC).
|
Yang, James Chih-Hsin; Ahn, Myung-Ju; Dickgreber, Nicolas J.; Halmos, Balazs; Hirsh, Vera; Hochmair, Maximilian J.; Levy, Benjamin Philip; De Marinis, Filippo; Mok, Tony; O'Byrne, Kenneth; Okamoto, Isamu; Schuler, Martin H.; Sebastian, Martin; Shah, Riyaz N. H.; Tan, Eng-Huat; Yamamoto, Nobuyuki; Marten, Angela; Massey, Dan; Wind, Sven; Carbone, David Paul; 楊志新 |
| 國立臺灣大學 |
2015 |
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
|
Yang, James Chih-Hsin; Wu, Yi-Long; Schuler, Martin; Sebastian, Martin; Popat, Sanjay; Yamamoto, Nobuyuki; Zhou, Caicun; Hu, Cheng-Ping; O'Byrne, Kenneth; Feng, Jifeng; Lu, Shun; Huang, Yunchao; Geater, Sarayut L.; Lee, Kye Young; Tsai, Chun-Ming; Gorbunova, Vera; Hirsh, Vera; Bennouna, Jaafar; Orlov, Sergey; Mok, Tony; Boyer, Michael; Su, Wu-Chou; Lee, Ki Hyeong; Kato, Terufumi; Massey, Dan; Shahidi, Mehdi; Zazulina, Victoria; Sequist, Lecia V.; 楊志新 |
| 國立臺灣大學 |
2015 |
Maintenance therapy with gefitinib (G)/pemetrexed (P) versus P alone after induction therapy with P/platinum for metastatic lung adenocarcinoma (MLADC) harboring no sensitizing epidermal growth factor receptor mutation (sEGFRm): A phase II multicenter randomized open-label study (GENIUS trial).
|
Tsai, Chun-Ming; Lai, Chun-Liang; Chiu, Chao-Hua; Hsia, Te-Chun; Chen, Chen-Hsin; Chang, Gee-Chen; Shih, Jin-Yuan; Ho, Ching-Liang; Chen, Yuh-Min; Yang, James Chih-Hsin; 楊志新; 施金元 |
| 國立臺灣大學 |
2015 |
Chloroquine Enhances Gefitinib Cytotoxicity in Gefitinib-Resistant Nonsmall Cell Lung Cancer Cells
|
Tang, Mei-Chuan; Wu, Mei-Yi; Hwang, Ming-Hung; Chang, Ya-Ting; Huang, Hui-Ju; Lin, Anya Maan-Yuh; Yang, James Chih-Hsin; 楊志新 |
| 國立臺灣大學 |
2015 |
A randomized Phase 3 study comparing first-line pemetrexed plus cisplatin followed by gefitinib maintenance (PC/G) with gefitinib monotherapy (G) in East Asian patients (pts) with locally advanced or metastatic nonsquamous non-small cell lung cancer (nSqNSCLC): Final survival results.
|
Yang, James Chih-Hsin; Srimuninnimit, Vichien; Ahn, Myung-Ju; Lin, Chia-Chi; Kim, Sang-We; Tsai, Chun-Ming; Mok, Tony; Orlando, Mauro; Puri, Tarun; Wang, Xin; Park, Keunchil; 林家齊; 楊志新 |
Showing items 1-50 of 101 (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page
|
